We had started bioscience business as a manufacture of Anti-leukocytes monoclonal antibodies (CD antibodies) in1983.
Nichirei Biosciences Inc. was reorganized on April 1, 2005 succeeding Nichirei’s bioscience business adopting the holding company system by our parent company Nichirei Corporation. Our mission is to contribute to the development and expansion of medical, cosmetic, and healthcare industries as a specialized company by offering high-quality products and services backed by our advanced technology.

Our business field ：

‧IHC (Immunohistochemistory) products (-Histofine®)
  We have developed state-of-the-art technology called UIP (Universal Immuno-enzyme Polymer) method. We manufacture and supply -Histofine® products utilized such UIP technology overseas. Also, we manufacture and supply several IVD products in IHC field domestically.

‧Diagnostic products (EIA and Lateral Flow Assay kits)
  We develop, manufacture and distribute several IVD products applied Immuno-reaction, especially POC (Point of Care) products for rapid diagnostics domestically.

‧Cell-Biology products and services
  We provide animal sera, media and services related to cell culture to the customers both in the academic and industrial fields domestically.

‧Functional Materials
  We develop functional materials from natural raw materials such as Acerola fruit procured by Nichirei group companies. We supply such functional materials to cosmetics and health food manufacturers domestically.